Samsung Biologics to provide fill-finish manufacturing for Moderna COVID vaccine
The CDMO will support the production of hundreds of millions of doses from its facility in Incheon, South Korea.
Samsung Biologics has signed a manufacturing services and supply agreement with Moderna in which the CDMO will provide large-scale, commercial fill-finish manufacturing for the biotech's COVID-19 vaccine, mRNA-1273.
Upon execution of the deal, tech transfer will start immediately and Samsung Biologics will perform aseptic fill-finish, labeling, and packaging services from its Incheon, South Korea site, to support the production of hundreds of millions of doses of Moderna’s COVID-19 vaccine, intended for the supply of markets outside of the US starting in the third quarter of 2021.
John Rim, CEO of Samsung Biologics, said that the company has "set immediate action plans and schedule to make mRNA-1273 available for commercial distribution in the early second half of 2021" in response to the immediate urgency of supplying the vaccine worldwide.
According to its Q1 2021 financial results report, Samsung Biologics says its existing plants are at near full operation. The construction of its Plant 4 or 'Super Plant' — what has been hailed as the world's largest biomanufacturing facility — also in Incheon, remains on track.
Related News
-
News Rebuilding the United States' pharma infrastructure – CPHI North America 2023 preview
As we prepare for CPHI North America from April 25–27 in Philadelphia, USA, CPHI Online caught up with some of the track sponsors to discuss how the show connects vital players within the North American pharmaceutical landscape. ... -
News Digital-first experimental approach to optimise drug formulations
Merck and XtalPi Inc. collaborate on an AI-powered technology platform to predict the crystal morphologies of diabetic medication metformin HCl, validated by wet-lab experiments conducted with Merck’s expertise, in a ‘digital-first’ a... -
News To recruit or to retain - where is the pharma talent going?
Discover how the pharmaceutical workforce has evolved past the pandemic, and the challenges faced by the pharma industry during a talent acquisition and retention crisis. -
News NextPharma acquisition of chewable tablet manufacturing site from Takeda complete
NextPharma has completed their acquisition of a Norway-based manufacturing site, specialising in chewable tablet technologies for calcium/vitamin D3 from pharmaceutical giant Takeda. -
News Doctors Without Borders demands transparency from GSK on licensing agreements for preventative HIV treatment
GSK has signed licensed agreements with three companies to manufacture generic versions of its preventative HIV medicine for distribution in lower-income countries but calls for increased transparency is putting pressure on the drugmaker. -
News Thermo Fisher Scientific and UCSF open cell therapy manufacturing facility
In collaboration with Thermo Fisher Scientific, UCSF has opened a new manufacturing site aimed at accelerating advanced cell and gene therapies for cancer, rare diseases, and other illnesses. -
News 3 ways ChatGPT will impact pharma marketing teams
What does the rise of AI-powered chatbots such as ChatGPT and GPT-4 mean for pharma marketeers? -
News Innovation in Drug Delivery & Portfolio Renovation with Sofgen Pharmaceuticals
The Pharma industry is expected to reach $1.9Tn in revenue by 2027, increasing at a rate of 3-6% per year, according to IQVIA1, with some regions being driven by volume, and others by innovation. Growth in developed economies is projected to be slow, w...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance